Loss of clusterin expression worsens renal ischemia-reperfusion injury

American Journal of Physiology - Renal Physiology

Volumn 298, Issue 3, 2010, Pages

  Zhou, Wenjun ^a,c   Guan, Qiunong ^a   Kwan, Chris C H ^a   Chen, Huifang ^c   Gleave, Martin E ^a   Nguan, Christopher Y C ^a,b   Du, Caigan ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Acute kidney injury; Apoptosis; Chaperone; Kidney ischemia; Transplantation

Indexed keywords

CLUSTERIN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE PREDISPOSITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY ISCHEMIA; KIDNEY TUBULE EPITHELIUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY;

EID: 77649161721     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00399.2009     Document Type: Article

References (63)

1. Aronow BJ, Lund SD, Brown TL, Harmony JA, Witte DP. Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci USA 90: 725-729, 1993.
2. Bellomo R, Auriemma S, Fabbri A, D'Onofrio A, Katz N, Mc-Cullough PA, Ricci Z, Shaw A, Ronco C. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs 31: 166-178, 2008.
3. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng PY, Sawczuk IS. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 9: 3473-3481, 1989.
4. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 16: 3015-3026, 2005.
5. Correa-Rotter R, Hostetter TH, Nath KA, Manivel JC, Rosenberg ME. Interaction of complement and clusterin in renal injury. J Am Soc Nephrol 3: 1172-1179, 1992.
6. Correa-Rotter R, Ibarra-Rubio ME, Schwochau G, Cruz C, Silkensen JR, Pedraza-Chaverri J, Chmielewski D, Rosenberg ME. Induction of clusterin in tubules of nephrotic rats. J Am Soc Nephrol 9: 33-37, 1998.
7. Du C, Guan Q, Diao H, Yin Z, Jevnikar AM. Nitric oxide induces apoptosis in renal tubular epithelial cells through activation of caspase-8. Am J Physiol Renal Physiol 290: F1044-F1054, 2006.
8. Du C, Wang S, Diao H, Guan Q, Zhong R, Jevnikar AM. Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameliorates renal ischemia-reperfusion injury. Am J Transplant 6: 2256-2267, 2006.
9. Dumont P, Burton M, Chen QM, Gonos ES, Frippiat C, Mazarati JB, Eliaers F, Remacle J, Toussaint O. Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast. Free Radic Biol Med 28: 361-373, 2000.
10. Dvergsten J, Manivel JC, Correa-Rotter R, Rosenberg ME. Expression of clusterin in human renal diseases. Kidney Int 45: 828-835, 1994.
11. Eddy AA, Fritz IB. Localization of clusterin in the epimembranous deposits of passive Heymann nephritis. Kidney Int 39: 247-252, 1991.
12. Edelstein CL, Ling H, Schrier RW. The nature of renal cell injury. Kidney Int 51: 1341-1351, 1997.
13. 1-42 and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures. J Neurochem 95: 715-723, 2005.
14. French LE, Tschopp J, Schifferli JA. Clusterin in renal tissue: preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli. Clin Exp Immunol 88: 389-393, 1992.
15. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 66: 486-491, 2004.
16. Gleave M, Chi KN. Knock-down of the cytoprotective gene, clusterin, to enhance hormone and chemosensitivity in prostate and other cancers. Ann NY Acad Sci 1058: 1-15, 2005.
17. Gleave ME, Zellweger T, Chi K, Miyake H, Kiyama S, July L, Leung S. Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer. Invest New Drugs 20: 145-158, 2002.
18. Gonzalez-Flecha B, Evelson P, Sterin-Speziale N, Boveris A. Hydrogen peroxide metabolism and oxidative stress in cortical, medullary and papillary zones of rat kidney. Biochim Biophys Acta 1157: 155-161, 1993.
19. Halliwell B. Oxidative stress in cell culture: an under-appreciated problem? FEBS Lett 540: 3-6, 2003.
20. Han BH, DeMattos RB, Dugan LL, Kim-Han JS, Brendza RP, Fryer JD, Kierson M, Cirrito J, Quick K, Harmony JA, Aronow BJ, Holtzman DM. Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat Med 7: 338-343, 2001.
21. Humes HD, Liu S. Cellular and molecular basis of renal repair in acute renal failure. J Lab Clin Med 124: 749-754, 1994.
22. Ishii A, Sakai Y, Nakamura A. Molecular pathological evaluation of clusterin in a rat model of unilateral ureteral obstruction as a possible biomarker of nephrotoxicity. Toxicol Pathol 35: 376-382, 2007.
23. Jevnikar AM, Brennan DC, Singer GG, Heng JE, Maslinski W, Wuthrich RP, Glimcher LH, Kelley VE. Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha. Kidney Int 40: 203-211, 1991.
24. Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol 34: 427-431, 2002.
25. July LV, Akbari M, Zellweger T, Jones EC, Goldenberg SL, Gleave ME. Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy. Prostate 50: 179-188, 2002.
26. July LV, Beraldi E, So A, Fazli L, Evans K, English JC, Gleave ME. Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo. Mol Cancer Ther 3: 223-232, 2004.
27. Kellum JA, Bellomo R, Ronco C. Definition and classification of acute kidney injury. Nephron Clin Pract 109: c182-c187, 2008.
28. Kevans D, Foley J, Tenniswood M, Sheahan K, Hyland J, O'Donoghue D, Mulcahy H, O'Sullivan J. High clusterin expression correlates with a poor outcome in stage II colorectal cancers. Cancer Epidemiol Biomarkers Prev 18: 393-399, 2009.
29. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 109: e102-e107, 2008.
30. McLaughlin L, Zhu G, Mistry M, Ley-Ebert C, Stuart WD, Florio CJ, Groen PA, Witt SA, Kimball TR, Witte DP, Harmony JA, Aronow BJ. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest 106: 1105-1113, 2000.
31. Michel D, Chatelain G, North S, Brun G. Stress-induced transcription of the clusterin/apoJ gene. Biochem J 328: 45-50, 1997.
32. Miyake H, Chi KN, Gleave ME. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo. Clin Cancer Res 6: 1655-1663, 2000.
33. Murphy BF, Davies DJ, Morrow W, d'Apice AJ. Localization of terminal complement components S-protein and SP-40,40 in renal biopsies. Pathology 21: 275-278, 1989.
34. Nath KA, Dvergsten J, Correa-Rotter R, Hostetter TH, Manivel JC, Rosenberg ME. Induction of clusterin in acute and chronic oxidative renal disease in the rat and its dissociation from cell injury. Lab Invest 71: 209-218, 1994.
35. Nee L, Tuite N, Ryan MP, McMorrow T. TNF-alpha and IL-1 betamediated regulation of MMP-9 and TIMP-1 in human glomerular mesangial cells. Nephron Exp Nephrol 107: e73-e86, 2007.
36. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, Brodsky S, Goligorsky MS. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 281: F948-F957, 2001.
37. Ortiz A, Justo P, Sanz A, Lorz C, Egido J. Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66: 1589-1594, 2003.
38. Partheen K, Levan K, Osterberg L, Claesson I, Fallenius G, Sundfeldt K, Horvath G. Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas. Int J Cancer 123: 2130-2137, 2008.
39. Peeters P, Terryn W, Vanholder R, Lameire N. Delayed graft function in renal transplantation. Curr Opin Crit Care 10: 489-498, 2004.
40. Perco P, Pleban C, Kainz A, Lukas A, Mayer B, Oberbauer R. Gene expression and biomarkers in renal transplant ischemia reperfusion injury. Transpl Int 20: 2-11, 2007.
41. Racusen LC, Monteil C, Sgrignoli A, Lucskay M, Marouillat S, Rhim JG, Morin JP. Cell lines with extended in vitro growth potential from human renal proximal tubule: characterization, response to inducers, and comparison with established cell lines. J Lab Clin Med 129: 318-329, 1997.
42. Rosenberg ME, Girton R, Finkel D, Chmielewski D, Barrie A, 3rd, Witte DP, Zhu G, Bissler JJ, Harmony JA, Aronow BJ. Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging. Mol Cell Biol 22: 1893-1902, 2002.
43. Rosenberg ME, Paller MS. Differential gene expression in the recovery from ischemic renal injury. Kidney Int 39: 1156-1161, 1991.
44. Safirstein R. Gene expression in nephrotoxic and ischemic acute renal failure. J Am Soc Nephrol 4: 1387-1395, 1994.
45. Saikumar P, Venkatachalam MA. Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 23: 511-521, 2003.
46. Saunders JR, Aminian A, McRae JL, O'Farrell KA, Adam WR, Murphy BF. Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney. Kidney Int 45: 817-827, 1994.
47. Sawczuk IS, Hoke G, Olsson CA, Connor J, Buttyan R. Gene expression in response to acute unilateral ureteral obstruction. Kidney Int 35: 1315-1319, 1989.
48. Schlegel PN, Matthews GJ, Cichon Z, Aulitzky WK, Cheng CY, Chen CL, Saso L, Goldstein M, Janne OA, Bardin CW, Darracott Vaughan E, Jr. Clusterin production in the obstructed rabbit kidney: correlations with loss of renal function. J Am Soc Nephrol 3: 1163-1171, 1992.
49. Schumer M, Colombel MC, Sawczuk IS, Gobe G, Connor J, O'Toole KM, Olsson CA, Wise GJ, Buttyan R. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140: 831-838, 1992.
50. Schwochau GB, Nath KA, Rosenberg ME. Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. Kidney Int 53: 1647-1653, 1998.
51. Silkensen JR, Agarwal A, Nath KA, Manivel JC, Rosenberg ME. Temporal induction of clusterin in cisplatin nephrotoxicity. J Am Soc Nephrol 8: 302-305, 1997.
52. Steinberg J, Oyasu R, Lang S, Sintich S, Rademaker A, Lee C, Kozlowski JM, Sensibar JA. Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer. Clin Cancer Res 3: 1707-1711, 1997.
53. Strocchi P, Smith MA, Perry G, Tamagno E, Danni O, Pession A, Gaiba A, Dozza B. Clusterin up-regulation following sub-lethal oxidative stress and lipid peroxidation in human neuroblastoma cells. Neurobiol Aging 27: 1588-1594, 2006.
54. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 170: 1517-1523, 2003.
55. Trougakos IP, Gonos ES. Clusterin/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 34: 1430-1448, 2002.
56. Trougakos IP, Gonos ES. Functional analysis of clusterin/apolipoprotein J in cellular death induced by severe genotoxic stress. Ann NY Acad Sci 1019: 206-210, 2004.
57. Viard I, Wehrli P, Jornot L, Bullani R, Vechietti JL, Schifferli JA, Tschopp J, French LE. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol 112: 290-296, 1999.
58. Wehrli P, Charnay Y, Vallet P, Zhu G, Harmony J, Aronow B, Tschopp J, Bouras C, Viard-Leveugle I, French LE, Giannakopoulos P. Inhibition of post-ischemic brain injury by clusterin overexpression. Nat Med 7: 977-979, 2001.
59. Wilson MR, Easterbrook-Smith SB. Clusterin is a secreted mammalian chaperone. Trends Biochem Sci 25: 95-98, 2000.
60. Witzgall R, Brown D, Schwarz C, Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93: 2175-2188, 1994.
61. Yamada K, Hori Y, Hanafusa N, Okuda T, Nagano N, Choi-Miura NH, Couser WG, Miyata T, Kurokawa K, Fujita T, Nangaku M. Clusterin is up-regulated in glomerular mesangial cells in complementmediated injury. Kidney Int 59: 137-146, 2001.
62. Ysebaert DK, De Greef KE, De Beuf A, Van Rompay AR, Vercauteren S, Persy VP, De Broe ME. T cells as mediators in renal ischemia/ reperfusion injury. Kidney Int 66: 491-496, 2004.
63. Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105: 1363-1371, 2000.